These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11552981)

  • 1. The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase.
    Vinatzer U; Taplick J; Seiser C; Fonatsch C; Wieser R
    Br J Haematol; 2001 Sep; 114(3):566-73. PubMed ID: 11552981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
    Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
    Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
    Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.
    Sitailo S; Sood R; Barton K; Nucifora G
    Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; van Putten WL; Valk PJ; van der Poel-van de Luytgaarde S; Hack R; Slater R; Smit EM; Beverloo HB; Verhoef G; Verdonck LF; Ossenkoppele GJ; Sonneveld P; de Greef GE; Löwenberg B; Delwel R
    Blood; 2003 Feb; 101(3):837-45. PubMed ID: 12393383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
    Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
    Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
    Cuenco GM; Ren R
    Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of EVI1 in normal and leukemic cells.
    Buonamici S; Chakraborty S; Senyuk V; Nucifora G
    Blood Cells Mol Dis; 2003; 31(2):206-12. PubMed ID: 12972028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling.
    Izutsu K; Kurokawa M; Imai Y; Maki K; Mitani K; Hirai H
    Blood; 2001 May; 97(9):2815-22. PubMed ID: 11313276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orphan nuclear receptor TR2 interacts directly with both class I and class II histone deacetylases.
    Franco PJ; Farooqui M; Seto E; Wei LN
    Mol Endocrinol; 2001 Aug; 15(8):1318-28. PubMed ID: 11463856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
    Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
    Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
    Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
    Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fadd and Skp2 are possible downstream targets of RUNX1-EVI1.
    Maki K; Sugita F; Nakamura Y; Sasaki K; Mitani K
    Int J Hematol; 2013 Jan; 97(1):83-91. PubMed ID: 23250858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on expression of Evi1 and MDS1-Evi1 genes in myelodysplastic syndromes].
    Xu K; Wang L; Hao Y
    Zhonghua Xue Ye Xue Za Zhi; 1998 Jun; 19(6):315-9. PubMed ID: 11243114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gfi-1 attaches to the nuclear matrix, associates with ETO (MTG8) and histone deacetylase proteins, and represses transcription using a TSA-sensitive mechanism.
    McGhee L; Bryan J; Elliott L; Grimes HL; Kazanjian A; Davis JN; Meyers S
    J Cell Biochem; 2003 Aug; 89(5):1005-18. PubMed ID: 12874834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
    Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
    Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
    Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
    Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evi-1 as a critical regulator of leukemic cells.
    Goyama S; Kurokawa M
    Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EVI1 gene in myeloid leukemia.
    Nucifora G
    Leukemia; 1997 Dec; 11(12):2022-31. PubMed ID: 9447815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.
    Vinatzer U; Mannhalter C; Mitterbauer M; Gruener H; Greinix H; Schmidt HH; Fonatsch C; Wieser R
    Genes Chromosomes Cancer; 2003 Jan; 36(1):80-9. PubMed ID: 12461752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.